350 rub
Journal №4 for 2013 г.
Article in number:
Investigation of antioxidant status of a patients which using omegalicin as a medicine for correction in the treatment of psoriasis
Authors:
R.N. Pavlova, L.A. Karyakina, Tch.R. Beyshebaeva, V.A. Dadali
Abstract:
Investigated possibility using the medicine «omegalicin» and vitamin \"C\" for correction together with traditional therapy for treatment of psoriasis. The problem of the work was a study of the condition antioxidant systems patients of psoriasis after administration a preparation, influencing upon intensity free radical oxidations. The condition of antioxidant systems valued on activities catalase, superoxide dismutase, glutathione peroxidase of blood, contents serum protein SH-groups and intensity hemiluminescention. In work was used designed prof. V.A.DADALI certified complex «omegalicin» (SR 77 99 23 3 beside 4224 6 07 from 15.06 2007г), containing ω-3 fat acids and extract of the garlic. Omega-3 fat acids are a source of eicosanoids and as unsaturated join present the substratum for lipid peroxidation. In previous study was discovered that level reconstruction equivalent increases of psoriatic patients, that promotes the reduction apoptosis and increasing to velocities of proliferation, and can be one of the reasons of the shaping psoriatic manifestation. Was found, that «Omegalicin» increased generation of reactive oxygen species, which necessary for decreases of proliferation by decrease activity of enzymes catalase, glutathionperoxidase, concentration protein SH-groups and increases to activity superoxide dismutase.
Pages: 69-72
References
  1. Arutjunjan A.V., Dubinina E.E., Zybina N.N. Metody ocenki svobodno-radikalnogo okislenija i antioksidantnojj sistemy. SPb. 2000.
  2. Grashin R.A., Barbino V.V., Antonov V.G. Aktivnost pro- i antioksidantnykh processov v kulturakh keratinocitov bolnykh psoriazom // Vestnik Rossijjkojj voenno-medicinskojj akademii. 2008. №4(24). S. 125-130.
  3. Grashin R.A. Antonov V.G., Karpishhenko A.I. i dr. Sistemy svobodnoradikalnogo okislenija i antioksidantnojj zashhity kak indikatory aktivnosti proliferacii keratinocitov pri psoriaze // Klinicheskaja laboratornaja diagnostika. 2010. № 1. S. 18-24.
  4. Gumejj P.D. i dr. Sostojanie pokazatelejj POL u bolnykh s psoriazom v zavisimosti ot stadii bolezni i lechenija // Patogenez i terapija kozhnykh i venericheskikh zabolevanijj. Vtorojj sezd dermatologov i venerologov. Mogilev. 1992. S. 96-97.
  5. Dadali V.A. Pavlova R.N., Karjakina L.A., Bejjshebaeva CH.R. i dr. Sostojanie nefermentativnogo zvena antioksidantnojj sistemy pri ispolzovanii omegalicina kak korregirujushhego preparata u bolnykh psoriazom // Sovremennye podkhody k metabolicheskojj korrekcii v profilaktike i terapii. Materialy mezhdunar. konf. SPb. 2009. S. 44-47.
  6. Dubinina E.E. Produkty metabolizma kisloroda v funkcio-
    nalnojj aktivnosti kletok (zhizn i smert, sozidanie i razrushenie). Fiziologicheskie i kliniko-biokhimicheskie aspekty. SPb. 2006.
  7. Klemenova I.A., Nikulin A.K., Alejjnik D.JA. i dr. Ultrastrukrurnye osobennosti membran fibroblastov kozhi pri psoriaze // Vestnik dermatologii i venerologii. 2007. № 3. S. 4-5.
  8. Kogteva G.S. i dr. Nenasyshhennye zhirnye kisloty kak ehndogennye bioreguljatory // Biokhimija. 1998. T. 61. Vyp. 1. S. 15-23.
  9. Korobejjnikova EH.N. Modifikacija opredelenija produktov perekisnogo okislenija lipidov v reakcii s tiobarbiturovojj kislotojj // Laboratornoe delo. 1989. № 7. S. 8-9.
  10. Pavlova R.N., Karjakina L.A., Golovanova N.EH i dr. Sostojanie pokazatelejj antioksidantnojj sistemy u bolnykh s psoriazom pri ispolzovanii poliena kak preparata korrekcii // Tez. dokl. Vseross. nauchn. konf. posvjashh. 110-letiju kafedry klinicheskojj biokhimii VMA. SPb. 2002. S. 70.
  11. Sokolovskijj V.V. Tiolovye antioksidanty v molekuljarnykh mekhanizmakh nespecificheskojj reakcii organizma na ehkstremalnoe vozdejjstvie // Voprosy medicinskojj khimii. 1988. Vyp. 6. S. 2-11.
  12. Sokolovskijj V.V. Tiol-disulfidnoe sootnoshenie krovi kak pokazatel sostojanija nespecificheskojj rezistentnosti organizma. SPb. 1996.
  13. Trofimova I.B., Kostjanova E.N., Koralkin A.V. i dr. Nekotorye aspekty patogeneza i lechenija psoriaza // Vestnik dermatologii i venerologii. 2004. № 5. S. 33-35.
  14. Turpaev K.T. Aktivnye formy kisloroda i reguljacija ehkpressii genoma // Biokhimija. 2002. T.67. № 3. S. 339-352.
  15. KHajjrutdinov V.R. Samcov A.V., Moshkalov A.V. i dr. Sovremennye predstavlenija ob immunnykh mekhanizmakh razvitija psoriaza // Vestnik dermatologii i venerologii. 2007. № 1. S. 3-7.
  16. SHilov V.N., Sergienko V.I. Novye podkhody k izucheniju patogeneza i lechenija psoriaza // Bjulleten ehksperimentalnojj biologii i mediciny. 2000. T. 129. № 4. S. 364 ? 369.
  17. SHilov V.N. Psoriaz - reshenie problemy (ehtiologija, patogenez, lechenie). M. 2001.
  18. Ellman G. Tissue sulfhydryl groups // Arh.Biochem. and Biophys. 1959.V. 82. P. 70 - 77.
  19. Krueger J.G., Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis // Ann. Rheumat. Dis. 2005. V. 64. P. 1130-1136.
  20. Pinto J.T. et al. Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture // Am. J. Clin. Nutr. 1997. V. 2. № 66. P. 398 - 405.
  21. Schmidt K.N. et all.Anti-psoriatic drug anthralin activates transcription factor NF-Karra-V in murine keratinocytes // Immunol. 1996. Jun 1. V. 156 (11). P. 4514-4519